2cmo

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:2cmo.gif|left|200px]]
[[Image:2cmo.gif|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 2cmo |SIZE=350|CAPTION= <scene name='initialview01'>2cmo</scene>, resolution 2.65&Aring;
+
The line below this paragraph, containing "STRUCTURE_2cmo", creates the "Structure Box" on the page.
-
|SITE= <scene name='pdbsite=AC1:M1l+Binding+Site+For+Chain+A'>AC1</scene>
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=GLU:GLUTAMIC+ACID'>GLU</scene>, <scene name='pdbligand=M1L:2-({[(3E)-5-{4-[(DIMETHYLAMINO)(DIHYDROXY)-LAMBDA~4~-SULFANYL]PHENYL}-8-METHYL-2-OXO-6,7,8,9-TETRAHYDRO-1H-PYRROLO[3,2-H]ISOQUINOLIN-3(2H)-YLIDENE]AMINO}OXY)-4-HYDROXYBUTANOIC+ACID'>M1L</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY=
+
or leave the SCENE parameter empty for the default display.
-
|GENE=
+
-->
-
|DOMAIN=
+
{{STRUCTURE_2cmo| PDB=2cmo | SCENE= }}
-
|RELATEDENTRY=
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2cmo FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2cmo OCA], [http://www.ebi.ac.uk/pdbsum/2cmo PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=2cmo RCSB]</span>
+
-
}}
+
'''THE STRUCTURE OF A MIXED GLUR2 LIGAND-BINDING CORE DIMER IN COMPLEX WITH (S)-GLUTAMATE AND THE ANTAGONIST (S)-NS1209'''
'''THE STRUCTURE OF A MIXED GLUR2 LIGAND-BINDING CORE DIMER IN COMPLEX WITH (S)-GLUTAMATE AND THE ANTAGONIST (S)-NS1209'''
Line 37: Line 34:
[[Category: Sigurskjold, B W.]]
[[Category: Sigurskjold, B W.]]
[[Category: Watjen, F.]]
[[Category: Watjen, F.]]
-
[[Category: alternative splicing]]
+
[[Category: Alternative splicing]]
-
[[Category: glycoprotein]]
+
[[Category: Glycoprotein]]
-
[[Category: ion channel]]
+
[[Category: Ion channel]]
-
[[Category: ion transport]]
+
[[Category: Ion transport]]
-
[[Category: ionic channel]]
+
[[Category: Ionic channel]]
-
[[Category: lipoprotein]]
+
[[Category: Lipoprotein]]
-
[[Category: membrane]]
+
[[Category: Membrane]]
-
[[Category: palmitate]]
+
[[Category: Palmitate]]
-
[[Category: postsynaptic membrane]]
+
[[Category: Postsynaptic membrane]]
-
[[Category: receptor]]
+
[[Category: Receptor]]
-
[[Category: rna editing]]
+
[[Category: Rna editing]]
-
[[Category: transmembrane]]
+
[[Category: Transmembrane]]
-
[[Category: transport]]
+
[[Category: Transport]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 22:31:32 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 02:23:38 2008''
+

Revision as of 19:31, 3 May 2008

Template:STRUCTURE 2cmo

THE STRUCTURE OF A MIXED GLUR2 LIGAND-BINDING CORE DIMER IN COMPLEX WITH (S)-GLUTAMATE AND THE ANTAGONIST (S)-NS1209


Overview

Ionotropic glutamate receptors (iGluRs) mediate fast synaptic transmission between cells of the central nervous system and are involved in various aspects of normal brain function. iGluRs are implicated in several brain disorders, e.g. in the high-frequency discharge of impulses during an epileptic seizure. (RS)-NS1209 functions as a competitive antagonist at 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionate receptors, and shows robust preclinical anticonvulsant and neuroprotective effects. This study explores 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionate receptor binding and selectivity of this novel class of antagonists. We present here the first X-ray structure of a mixed GluR2 ligand-binding core dimer, with the high-affinity antagonist (S)-8-methyl-5-(4-(N,N-dimethylsulfamoyl)phenyl)-6,7,8,9,-tetrahydro-1H-py rrolo[3,2-h]-isoquinoline-2,3-dione-3-O-(4-hydroxybutyrate-2-yl)oxime [(S)-NS1209] in one protomer and the endogenous ligand (S)-glutamate in the other. (S)-NS1209 stabilises an even more open conformation of the D1 and D2 domains of the ligand-binding core than that of the apo structure due to steric hindrance. This is the first time ligand-induced hyperextension of the binding domains has been observed. (S)-NS1209 adopts a novel binding mode, including hydrogen bonding to Tyr450 and Gly451 of D1. Parts of (S)-NS1209 occupy new areas of the GluR2 ligand-binding cleft, and bind near residues that are not conserved among receptor subtypes. The affinities of (RS)-NS1209 at the GluR2 ligand-binding core as well as at GluR1-6 and mutated GluR1 and GluR3 receptors have been measured. Two distinct binding affinities were observed at the GluR3 and GluR4 receptors. In a functional in vitro assay, no difference in potency was observed between GluR2(Q)(o) and GluR3(o) receptors. The thermodynamics of binding of the antagonists (S)-NS1209, DNQX and (S)-ATPO to the GluR2 ligand-binding core have been determined by displacement isothermal titration calorimetry. The displacement of (S)-glutamate by all antagonists was shown to be driven by enthalpy.

About this Structure

2CMO is a Single protein structure of sequence from Rattus norvegicus. Full crystallographic information is available from OCA.

Reference

The structure of a mixed GluR2 ligand-binding core dimer in complex with (S)-glutamate and the antagonist (S)-NS1209., Kasper C, Pickering DS, Mirza O, Olsen L, Kristensen AS, Greenwood JR, Liljefors T, Schousboe A, Watjen F, Gajhede M, Sigurskjold BW, Kastrup JS, J Mol Biol. 2006 Apr 7;357(4):1184-201. Epub 2006 Jan 31. PMID:16483599 Page seeded by OCA on Sat May 3 22:31:32 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools